Top-News
Biotechnologie Dänemark

Genmab News

Aktie
WKN:  565131 ISIN:  DK0010272202 US-Symbol:  GNMSF
273,40 €
+0,30 €
+0,11%
17.05.24 16:47:20
Handeln Depot/Watchlist
Aktienanzahl *
65,39 Mio.
Marktkapitalisierung *
18,13 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 06.11.2023

Unternehmensmeldungen

14.08.13 - DGAP
Genmab Announces Financial Results for the First Half of 2013 and Improves 2013 Financial Guidance
Genmab A/S 14.08.2013 17:08 --------------------------------------------------------------------------- August 14, 2013; Copenhagen, Denmark; Interim Report First Half 2013 -- Reported positive ...
17.06.13 - DGAP
Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhead
Genmab A/S 17.06.2013 07:31 --------------------------------------------------------------------------- Media Release -- Antibody-​drug conjugate (ADC) to be developed for cancer -- Combines ...
07.05.13 - DGAP
Genmab Announces Financial Results for the First Quarter of 2013
Genmab A/S 07.05.2013 17:02 --------------------------------------------------------------------------- May 7, 2013; Copenhagen, Denmark; Interim Report First Quarter 2013 -- Arzerra(r) received ...
07.03.13 - DGAP
Genmab 2012 Annual Report
Genmab A/S 07.03.2013 17:02 --------------------------------------------------------------------------- Company Announcement Copenhagen, Denmark; March 7, 2013 - Genmab A/S (OMX: GEN) ...
24.01.13 - DGAP
Major Shareholder Announcement
Genmab A/S 24.01.2013 17:42 --------------------------------------------------------------------------- Company Announcement -- Major shareholder announcement for Genmab A/S Copenhagen, ...
07.11.12 - DGAP
CORRECTION: Genmab Announces Financial Results for the First Nine Months of 2012 and Improves 2012 Financial Guidance
Genmab A/S 07.11.2012 17:09 --------------------------------------------------------------------------- November 7, 2012; Copenhagen, Denmark; Interim Report for the 9 Months Ended September ...
07.11.12 - DGAP
Genmab Announces Financial Results for the First Half 2012 and Improves 2012 Financial Guidance
Genmab A/S 07.11.2012 17:01 --------------------------------------------------------------------------- November 7, 2012; Copenhagen, Denmark; Interim Report for the 9 Months Ended September ...
16.10.12 - DGAP
Major Shareholder Announcement
Genmab A/S 16.10.2012 15:25 --------------------------------------------------------------------------- Company Announcement -- Major shareholder announcement for Genmab A/S Copenhagen, ...
16.10.12 - DGAP
Capital Increase in Genmab as a Result of Execution of a Private Placement to Johnson & Johnson Development Corporation
Genmab A/S 16.10.2012 09:12 --------------------------------------------------------------------------- Company Announcement -- Genmab increases its share capital by nominally DKK 5,400,000 ...
15.08.12 - DGAP
Genmab Announces Financial Results for the First Half 2012 and Improves 2012 Financial Guidance
Genmab A/S 15.08.2012 17:02 --------------------------------------------------------------------------- August 15, 2012; Copenhagen, Denmark; Interim Report for the First Half 2012 -- DuoBody(tm) ...
15.05.12 - DGAP
Genmab Announces Financial Results for the First Quarter 2012
Genmab A/S 15.05.2012 17:01 --------------------------------------------------------------------------- May 15, 2012; Copenhagen, Denmark; Interim Report for the First Quarter 2012 -- Arzerra(r) net ...
03.08.11 - DGAP
Interim Report for the 6 months ended June 30, 2011 deutsch
Genmab A/S;DK0010272202;;;;;EN;DK;; DGAP-News: Genmab A/S Genmab A/S Interim Report for the 6 months ended June 30, 2011 03.08.2011 17:31 --------------------------------------...
24.09.03 - Hugin
Genmab A/S (DK) - Genmab Initiates Phase I/II Trial Using HuMax-EG ...
Published: 16:49 24.09.2003 GMT+2 /HUGIN /Source: Genmab A/S /CSE: GENM /ISIN: DK0010272202 Genmab Initiates Phase I/II Trial Using HuMax-​EGFr to Treat Cancer Genmab ...
18.09.03 - Hugin
Genmab A/S (DK) - Genmab to Present at UBS Global Life Sciences Co ...
Published: 12:47 18.09.2003 GMT+2 /HUGIN /Source: Genmab A/S /CSE: GENM /ISIN: DK0010272202 Genmab to Present at UBS Global Life Sciences Conference 2003 ...
16.09.03 - Hugin
Genmab A/S (DK) - Genmab Achieves Milestone in Amgen License Agreement
Published: 16:52 16.09.2003 GMT+2 /HUGIN /Source: Genmab A/S /CSE: GENM /ISIN: DK0010272202 Genmab Achieves Milestone in Amgen License Agreement Genmab has ...
29.08.03 - Hugin
Genmab A/S (DK) - Genmab Publishes Investment Memorandum
Published: 18:14 29.08.2003 GMT+2 /HUGIN /Source: Genmab A/S /CSE: GENM /ISIN: DK0010272202 Genmab Publishes Investment Memorandum Genmab publishes an ...
06.08.03 - Hugin
Genmab A/S (DK) - Genmab Announces 2003 First Half Year Results
Published: 18:26 06.08.2003 GMT+2 /HUGIN /Source: Genmab A/S /CSE: GENM /ISIN: DK0010272202 Genmab Announces 2003 First Half Year Results Genmab presents results ...
14.07.03 - Hugin
Genmab A/S (DK) - Genmab Expands Pipeline with Hepatitis Antibody
Published: 09:32 14.07.2003 GMT+2 /HUGIN /Source: Genmab A/S /CSE: GENM /ISIN: DK0010272202 Genmab Expands Pipeline with Hepatitis Antibody Genmab acquires the ...
01.07.03 - Hugin
Genmab A/S (DK) - Amgen Exercises Commercial Option to Genmabs HuM ...
Published: 08:30 01.07.2003 GMT+2 /HUGIN /Source: Genmab A/S /CSE: GENM /ISIN: DK0010272202 Amgen Exercises Commercial Option to Genmab's HuMax-IL15 Genmab ...
27.06.03 - Hugin
Genmab A/S (DK) - Genmab Files CTA for HuMax-EGFr to Treat Cancer
Published: 10:55 27.06.2003 GMT+2 /HUGIN /Source: Genmab A/S /CSE: GENM /ISIN: DK0010272202 Genmab Files CTA for HuMax-​EGFr to Treat Cancer Genmab files Clinical ...

Newssuche

Videos

17.05.24 +14,15%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »